EmailHyperstimulation of uterus due to syntocinon infusion
Publication Date: June 2010
Implementation Date: 1/06/2022
Updated Date: 31/05/2022
ICD 10 AM Edition: Eleventh Edition
Query Number: 2528
In a recent coding meeting HIMs reported that they are increasingly seeing documention in the medical record of hyperstimulation of the uterus due to syntocinon infusion. This often results in the syntocinon infusion being decreased or stopped completely
Currently this is coded to O62.4 Hypertonic, incoordinate, and prolonged uterine contractions as this is seen to be the best fit code.
Can the committee please advise whether the one code appropriately captures this diagnosis or whether coders should code this diagnosis as an adverse drug reaction as below.
O62.4 Hypertonic, incoordinate, and prolonged uterine contractions
Y55.0 Oxytocic drugs
Y92.22 Health service area
Currently this is coded to O62.4 Hypertonic, incoordinate, and prolonged uterine contractions as this is seen to be the best fit code.
Can the committee please advise whether the one code appropriately captures this diagnosis or whether coders should code this diagnosis as an adverse drug reaction as below.
O62.4 Hypertonic, incoordinate, and prolonged uterine contractions
Y55.0 Oxytocic drugs
Y92.22 Health service area
Response
This query was originally published in June 2010 (and retired on 30 June 2015) as follows:
The intent of syntocinon is to stimulate the uterus and it is standard obstetric care to adjust the dose based on the patient's response. Management of the dose is essential to prevent hyperstimulation while at the same time providing enough stimulation to achieve the desired outcome.
VICC considers O62.4 Hypertonic, incoordinate, and prolonged uterine contractions is the correct code to assign for documentation of hyperstimulation of the uterus following index entry Contraction, uterus, abnormal, hypertonic.
If documentation supports a link between the hyperstimulation and the proper use of syntocinon, follow ACS 1902 Adverse effects and assign additional codes to indicate an adverse effect.[end of orignal response].
Following a review by the committee the response has been determined to be current and has been updated for clarity as follows:
The intent of syntocinon is to stimulate the uterus and it is standard obstetric care to adjust the dose based on the patient's response. Management of the dose is essential to prevent hyperstimulation while at the same time providing enough stimulation to achieve the desired outcome. Hyperstimulation of uterus is also known as hypertonic uterine dysfunction.
For documentation of hyperstimulation of uterus that meets ACS 0002 Additional diagnosis criteria VICC considers O62.4 Hypertonic, incoordinate, and prolonged uterine contractions is the correct code to assign for documentation of hyperstimulation of the uterus following Index entry Contraction, uterus, abnormal, hypertonic.
If documentation supports a link between the hyperstimulation and the proper use of syntocinon, follow ACS 1902 Adverse effects and assign additional codes to indicate an adverse effect.
The intent of syntocinon is to stimulate the uterus and it is standard obstetric care to adjust the dose based on the patient's response. Management of the dose is essential to prevent hyperstimulation while at the same time providing enough stimulation to achieve the desired outcome.
VICC considers O62.4 Hypertonic, incoordinate, and prolonged uterine contractions is the correct code to assign for documentation of hyperstimulation of the uterus following index entry Contraction, uterus, abnormal, hypertonic.
If documentation supports a link between the hyperstimulation and the proper use of syntocinon, follow ACS 1902 Adverse effects and assign additional codes to indicate an adverse effect.[end of orignal response].
Following a review by the committee the response has been determined to be current and has been updated for clarity as follows:
The intent of syntocinon is to stimulate the uterus and it is standard obstetric care to adjust the dose based on the patient's response. Management of the dose is essential to prevent hyperstimulation while at the same time providing enough stimulation to achieve the desired outcome. Hyperstimulation of uterus is also known as hypertonic uterine dysfunction.
For documentation of hyperstimulation of uterus that meets ACS 0002 Additional diagnosis criteria VICC considers O62.4 Hypertonic, incoordinate, and prolonged uterine contractions is the correct code to assign for documentation of hyperstimulation of the uterus following Index entry Contraction, uterus, abnormal, hypertonic.
If documentation supports a link between the hyperstimulation and the proper use of syntocinon, follow ACS 1902 Adverse effects and assign additional codes to indicate an adverse effect.
